Log In
Join
GCI
29th October 2024
07:00
Shield Therapeutics - Q3 Trading Update
25th September 2024
06:00
Shield Therapeutics - Results from Phase 3 paediatric study
4th September 2024
06:00
Shield Therapeutics - Interim results
27th August 2024
06:00
Shield Therapeutics - ACCRUFeR® Approved by Health Canada
14th August 2024
06:00
Shield Therapeutics - Notice of interim results
24th July 2024
06:01
Shield Therapeutics - Unaudited Q2 2024 Trading Update
24th July 2024
06:00
Shield Therapeutics - Directorate Change
3rd July 2024
06:00
Shield Therapeutics - $5.7m Milestone Monetization Agreement with AOP
20th June 2024
15:25
Shield Therapeutics - Results of 2024 Annual General Meeting
28th May 2024
06:00
Shield Therapeutics - New Drug Application for Accrufer® in South Korea
10th May 2024
14:30
Shield Therapeutics - Audited results for the year ended 31 Dec 2023
30th April 2024
06:00
Shield Therapeutics - Business Update for Q1 2024
Load more
Shield Therapeutics Plc (STX.L)
Share Price & News
Follow
Unfollow
Price Snapshot
Last Trades
Bid
-
-
-
Ask
High
-
OPEN
-
VOL
-
MKT CAP
-M
LOW
-
CLOSE
-
SHARES IN ISSUE
782.06M
Profile
Financials
RNS
Chart
Media
Board & Advisors
More...
Watchlist